Proinflammatory cytokines target vascular endothelial cells during COVID-19 infections. In
particular, the endothelial glycocalyx (eGC), a proteoglycan-rich layer on top of endothelial …

COVID-19 is a respiratory infection caused by the highly transmissible SARS-CoV-2. While
most infected patients exhibit mild to moderate symptoms, a minority may develop severe …

The coronavirus disease 2019 (COVID-19) has emerged as a global burden comprising
cardiovascular and respiratory complications. Herein, endothelial cell infection causing …

The potential for a rapid increase in severity is among the most frightening aspects of severe
acute respiratory syndrome coronavirus 2 infection. Evidence increasingly suggests that the …

Damage of the endothelial glycocalyx (eGC) plays a central role in the development of
vascular hyperpermeability and organ damage during systemic inflammation. However, the …

COVID-19 is a highly infectious respiratory disease caused by a new coronavirus known as
SARS-CoV-2. COVID-19 is characterized by progressive respiratory failure resulting from …

The severe forms and worsened outcomes of COVID-19 (coronavirus disease 19) are
closely associated with hypertension and cardiovascular disease. Endothelial cells express …

Since March 2020, the world has been fighting a global pandemic caused by a new
coronavirus SARS-CoV-2 (COVID-19). SARS-CoV-2 is responsible for severe acute …

Background Degradation of the endothelial protective glycocalyx layer during COVID-19
infection leads to shedding of major glycocalyx components. These circulating proteins and …

Purpose Vascular and immune dysfunction are hallmarks of severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) infections and coronavirus disease 2019 (COVID …